HOME >> MEDICINE >> NEWS
New Contact Lens Material Could Lessen Risk Of Eye Infection

ANAHEIM, Calif., March 22 -- New materials that may extend the wear of contact lenses and lessen the risk of eye infection were described by researchers from the University of California, Berkeley, today at the national meeting of the American Chemical Society, the world's largest scientific society.

The material, called a sulfoxide hydrogel polymer, enhances the water level in the eye while minimizing undesirable protein buildup. Scientists claim it will enable contact lenses to be worn for longer periods of time, prevent bacterial buildup in the eye, and increase comfort. "The excess water in the lens makes it softer and, therefore, more comfortable to the wearer, besides providing much required oxygen to the eye," says Dr. Ravi Mukkamala, who presented the findings.

Dr. Mukkamala, who currently works as a senior scientist at Rohm and Haas Texas Inc. in Houston, was the co-inventor of the materials, along with Prof. Carolyn Betozzi in the chemistry dept. of UC Berkeley. What makes the materials unique, they say, is the addition of sulfoxide groups to the hydrogel polymer.

Currently, soft contact lenses made from hydrogels are capable of holding water, but not without greatly affecting the protein deposition. In conventional lenses, any chemical modification made to the lens material to increase the water level -- an important component in supplying oxygen to the eye -- adversely increases the protein deposition on the lens surface. This increase in protein could lead to such problems as infections and blurred vision.

"The sulfoxide hydrogels, on the other hand, possess characteristics that set them apart from the rest of the hydrogel systems," says Mukkamala, and may offer fresh possibilities for the design of new materials where wettability and bulk hydrophilicity are important factors.

The sulfoxide hydrogel lenses, currently undergoing clinical trials, could be available as early as next year.


'"/>

Contact: Charmayne Marsh
y_marsh@acs.org
202-872-4445
American Chemical Society
23-Mar-1999


Page: 1

Related medicine news :

1. Contact lenses that dispense prescription drugs
2. Contact lens solutions may not kill off harmful eye bugs
3. Material could lead to self-healing cavities
4. Material that made car bumpers shine finds a role in manufacture of drugs, dyes
5. Could skin cells become brain cells?
6. Could autoantibodies predict future disease in healthy people?
7. Could this be the end for injections?
8. Could you suffer from psychosis? The nose knows
9. Could a mandated food additive aimed at better fetal development be a risk for seniors?
10. Could an aspirin a day help keep prostate cancer away? Possibly
11. Drug blocks opioid side effects: Could improve palliative care

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Contact Lens Material Could Lessen Risk Eye Infection

(Date:5/18/2013)... 2013 The “World Healthcare IT Market: ... the major market drivers, restraints, and opportunities in North ... Browse , 89 market data ... on "Healthcare IT Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html ... reports. , The global healthcare IT market is expected ...
(Date:5/18/2013)... May 18, 2013 During Better Hearing ... should consider the legal protections they have, including the ... arise with their child’s treatment or hearing aid device, ... 1927, the American Speech-Language-Hearing Association has used the month ... to promote treatment, such as cochlear implants, which can ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment with synthetic ... landing in emergency rooms across America. Recovery ... with a new treatment program for those addicted to ... the National Institute on Drug Abuse, synthetic marijuana has ... In 2012, 11 percent of high school seniors had ...
(Date:5/18/2013)... May 18, 2013 The American ... John A. Kitzhaber, M.D., (D) to sign a bill ... prohibiting minors under the age of 18 from tanning ... the third state in the nation to enact an ... similar indoor tanning bans for minors. Nationwide, 34 states ...
(Date:5/18/2013)... The topics that will be covered in the 1-day ... meetings, scrum artifacts, and scrum simulation (optional). One can earn ... These trainings are suitable for business analysts, project managers, developers, ... will be a part of the Scrum team, people outside ... and Scrum, but are unsure of what it is. ...
Breaking Medicine News(10 mins):Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ... today that the United States Food and Drug Administration ... for ORMD-0801, its oral insulin capsule. "We ... proceed," stated Nadav Kidron , CEO ... for Oramed and we look forward to continuing to ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Technology and Research (A*STAR) and Switzerland,s ... has been dosed in a Phase 1 clinical trial with ... Qbeta virus-like particle (VLP) technology. In this first Phase 1 ... candidate and its potential to protect against H1N1 influenza infection ...
(Date:5/16/2013)... , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... W. Robin , is scheduled to present at the ... York at the Sheraton New York Hotel on ... The presentation will be accessible via a Webcast through ... of the Nektar website: http://www.nektar.com . This Webcast will ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
Cached News: